NOROVIRUS-IMPFSTOFF-FORMULIERUNGEN

Patent europeic · EP2601970 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2601970
Numer da la dumonda
EP13157573
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
28-09-2007
Publitgà
12-06-2013
Concedì
26-10-2016
Stritgà
14-09-2022
Motiv
Revocà en la procedura d’opposiziun
Classas IPC
A61K 39/42 (2006.01)
A61K 39/12 (2006.01)
Prioritad
US 847912 P 29.09.2006
US 973392 P 18.09.2007
Derivà da
EP07853688
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 14-09-2022

    Midada

    Published in Swissreg on 14.09.2022

  2. 23-09-2021

    Midada

    Published in Swissreg on 23.09.2021

  3. 23-09-2021

    Midada

    Published in Swissreg on 23.09.2021

  4. 26-10-2016

    Concedì

    Published in Swissreg on 26.10.2016

Partidas

Possessur

Takeda Vaccines, Inc.

One Takeda Parkway, Deerfield, IL 60015, US

Inventur

Richardson, Charles

Deerfield, IL 60015, US

Vedvick, Thomas S.

Deerfield, IL 60015, US

Foubert, Thomas R.

Deerfield, IL 60015, US

Tino, William T.

Deerfield, IL 60015, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.